Stage IV Salivary Gland Cancer Completed Phase 1 Trials for Sargramostim (DB00020)

Also known as: Salivary gland cancer stage IV / Metastatic salivary gland cancer / Malignant salivary gland cancer stage IV

IndicationStatusPhase
DBCOND0028780 (Stage IV Salivary Gland Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00028496Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerTreatment